Trials / Conditions / Stage III Gallbladder Cancer AJCC v8

Stage III Gallbladder Cancer AJCC v8

6 registered clinical trials studyying Stage III Gallbladder Cancer AJCC v8.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co NCT05564403	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladde NCT04559139	ECOG-ACRIN Cancer Research Group	Phase 2 / Phase 3
Active Not Recruiting	Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Me NCT04068194	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer NCT04072445	Mayo Clinic	Phase 2
Withdrawn	Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer NCT03579758	Emory University	Phase 3
Completed	Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnos NCT03768414	SWOG Cancer Research Network	Phase 3